We are live on ! Find out more
ASB

AdvanSource Biomaterials Corp
ASB

Delisted

ASB was delisted on the 23rd of November, 2010.

Back to rankings

1 hedge funds and large institutions have $1K invested in AdvanSource Biomaterials Corp in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JEW
Jamison Eaton & Wood
New Jersey
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
JEW
1
Jamison Eaton & Wood
New Jersey
$1K +$1K +8,457 New

ASB Hedge Fund Activity: Q3 2013 in Review

1 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in AdvanSource Biomaterials Corp (ASB) for Q3 2013, worth a combined $1K.

Buyers outnumbered sellers: 1 fund opened new ASB positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Jamison Eaton & Wood, opening a new position worth an estimated $1K.

  • 1 institutional investor held AdvanSource Biomaterials Corp (ASB) as of Q3 2013, up from 0 in Q2 2013.
  • Funds reported $1K of AdvanSource Biomaterials Corp stock for Q3 2013.
  • 1 fund opened new AdvanSource Biomaterials Corp positions in Q3 2013 and 0 closed out, a net change of +1 holder.
  • The largest AdvanSource Biomaterials Corp buyer in Q3 2013 was Jamison Eaton & Wood, an estimated $1K added.

Based on aggregated 13F filings for Q3 2013.